Search
for
Sort by
Research 241–270 of 552
- Design, synthesis and biological evaluation of novel androst-3,5-diene-3-carboxylic acid derivatives as inhibitors of 5α-reductase type 1 and 2
- Homology Modeling of 5-alpha-Reductase 2 Using Available Experimental Data
- Activity of steroid 4 and derivatives 4a–4f as inhibitors of the enzyme 5α-reductase 1
- A method for simultaneous analysis of androgens, dutasteride and finasteride in human serum by liquid chromatography tandem mass spectrometry
- Investigation on the Mechanism of <i>Platycladus</i> <i>orientalis</i> in the Treatment of Androgenetic Alopecia Based on Machine Learning and Molecular Dynamics
- Increased Incidence of Telogen Effluvium Following Platelet-Rich Plasma Therapy in Patients with Elevated TNF-α Expression: A Prospective Cohort Study
- Nanotechnology-based topical treatments for androgenic alopecia
- Highlights from JAAD Reviews: August 2025—Bicalutamide for female hair loss
- Long-term use of dutasteride to treat androgenic alopecia in young men may lead to persistent abnormalities in semen parameters
- Loss of epidermal PLCg1 induced sebaceous gland hyperplasia and sparse hair
- Synthesis of avicequinone c and analogs toward the study of 5α-reductase inhibitory activity
- Caffeic acid N-[3,5-bis(trifluoromethyl)phenyl] amide as a non-steroidal inhibitor for steroid 5α-reductase type 1 using a human keratinocyte cell-based assay and molecular dynamics
- Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.
- Anticonvulsant Activity of Progesterone and Neurosteroids in Progesterone Receptor Knockout Mice
- Testosterone modulation of seizure susceptibility is mediated by neurosteroids 3α-androstanediol and 17β-estradiol
- Steroid 5α-reductases and 3α-hydroxysteroid dehydrogenases: key enzymes in androgen metabolism
- Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: A randomized, double-blind, placebo-controlled, phase III study
- The Effect of 5α-Reductase Inhibition With Dutasteride and Finasteride on Bone Mineral Density, Serum Lipoproteins, Hemoglobin, Prostate Specific Antigen and Sexual Function in Healthy Young Men
- The enzyme and inhibitors of 4-ene-3-oxosteroid 5α-oxidoreductase
- Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride
- Finasteride, a 5alpha-reductase inhibitor, blocks the anticonvulsant activity of progesterone in mice.
- 17 beta-hydroxysteroid dehydrogenase 3 deficiency in the Mediterranean population.
- Dutasteride
- 5-α-Reductase type 2 deficiency: is there a genotype-phenotype correlation? A review
- A Review of the FAERS Data on 5-Alpha Reductase Inhibitors: Implications for Postfinasteride Syndrome
- Patients with a large prostate show a higher prevalence of androgenetic alopecia
- Immunohistochemical expressions of mGluR5, P2Y2 receptor, PLC-?1, and IP3R-I and -II in Merkel cells in rat sinus hair follicles
- Neonatal finasteride induces anxiogenic-like profile and deteriorates passive avoidance in adulthood after intrahippocampal neurosteroid administration
- Herbal Extracts Induce Dermal Papilla Cell Proliferation of Human Hair Follicles
- Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It’s Time to Sound the Alarm